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Background: The aim of the present study was to evaluate the expressions
and biological functions of the TGF-b1/Smad signalling pathway of aortic disor-
ders by way of histopathological and immunohistochemical studies.
Material and methods: Aortic specimens of 20 patients with aortic dissection,
9 patients with aortic aneurysm, 9 patients with coronary artery disease, and 5 de-
ceased healthy adults were collected. The samples were stained with haematoxylin-
-eosin, Masson’s trichrome, van Gieson, and alcian blue, and with immunohistochemi-
cal stainings to detect TGF-b1, type I receptor (TbRI), Smad2/3, Smad4, and Smad7.
Results: Masson’s trichrome and van Gieson stainings showed attenuated col-
lagens in the aorta of the patients with aortic dissection and aortic aneurysm. TGF-
-b1, TbRI, and Smad2/3 mainly showed a cytoplasmic immunoreactivity in the aor-tic
media, Smad4 immunoreactivity was predominantly located in the cytoplasm and/
/or the nucleus of the aortic media, and Smad7 immunoreactivity was present in
the nucleus of the aortic media and intima. The TGF-b1 signalling pathway proteins
were similarly expressed in the aorta of aortic dissection and aortic aneurysm pa-
tients, while they were less pronounced in the aorta of coronary artery disease
patients, and weak or negative in the aorta of healthy control individuals.
Conclusions: These observations support the notion that there is an associa-
tion between the TGF-b1/Smad pathway and the pathological events of the
aorta. Dysregulation of the TGF-b1/Smad pathway may predispose the patho-
logenesis of aortic disorders. (Folia Morphol 2012; 71, 1: 31–38)
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INTRODUCTION
Transforming growth factor (TGF)-b is a secret-
ed protein that may regulate cell growth, cell pro-
liferation, cell differentiation, and apoptosis. Smad
proteins are responsible for transferring TGF-b
signals from the receptors from the cell mem-
brane to the nucleus. There are 3 types of func-
tioning Smad proteins: receptor-regulated Smads
(R-Smads) including Smad1, Smad2, Smad3, Smad5,
and Smad8, which are directly phosphorylated and
activated by the type I receptor (TbRI) kinases to
form heteromeric complexes with the common me-
diator Smad (Co-Smad) Smad4; and Inhibitory
Smads (I-Smads) including Smad 6 and Smad7,
which may bind to TbRI to inhibit the signalling
transfer [1, 18].
32
Folia Morphol., 2012, Vol. 71, No. 1
Studies have shown that TGF-b1 was typically
associated with proliferation processes and extra-
cellular matrix accumulation leading to fibrosis in
models of mesangial proliferative glomerulonephri-
tis [4], hepatic fibrosis [7], and dermal tumours [16].
Upregulated expressions of TGF-b1 in the renal in-
terstitium may indicate a transformation from the
endothelial cells to fibroblasts [14]. TbRI and type II
receptor (TbRII) immunoreactivities were expressed
more intensely in the dermatofibroma than in the
normal dermal tissues, while their stainings were
weak in the dermatofibrosarcoma protuberans [16].
Aortic dissection is a potentially life-threatening con-
dition that is often present in young individuals with
a medical history of hypertension. Extensive studies have
been made on the pathogenesis of aortic dissection in
terms of sulphated glycosaminoglycans [13], and the
enzymes in the extracellular matrix, such as matrix met-
alloproteinases and tissue inhibitor of metalloprotein-
ases [24]. TGF-b bioavailability has been proven to be
a risk factor for aortic aneurysmal progression in mice
models [6]. However, the implications of TGF-b signal-
ling pathway in aortic dissection have not been fully
elucidated as yet. In order to highlight the biological
roles that TGF-b1 signalling play in the pathogenesis of
aortic disorders, the present study was designed to in-
vestigate the expressions and localisations of TGF-b1 and
the pertinent Smad proteins of the signalling pathway
in the aorta of patients with aortic dissection, aortic
aneurysm, and coronary artery disease, in comparison
to healthy controls by way of histopathological and im-
munohistochemical studies.
MATERIAL AND METHODS
From 2008 to the present, 20 patients with acute
aortic dissection (Aortic Dissection Group), 9 patients
with aortic aneurysm (Aortic Aneurysm Group), and
9 patients with coronary artery disease for coronary ar-
tery bypass (Coronary Artery Disease Group) were ran-
domly selected into this study. Severed samples of the
anterior walls of the ascending aorta were obtained
from the first two groups of patients during the surgi-
cal operations, and surgical specimens of the anterior
walls of the ascending aorta from the aortic anasto-
motic sites of patients with coronary artery disease
were taken as experimental, and the ascending aorta
at the corresponding sites from 5 deceased adults who
had no underlying healthy issues (Healthy Control
Group) were taken as control samples. No differences
were found in patients’ age between the groups. Pa-
tients with Marfan’s syndrome were excluded from
this study. Table 1 shows the demographics of the
Table 1. Demographics of the study subjects
Group Aortic dissection Aortic aneurysm CAD Healthy control
Case (n) 20 9 9 5
Female gender 2 3 2 2
Age (year) (range) 53.78 ± 9.67 (28–72) 46.20 ± 11.16 (42–69) 60.33 ± 4.87 (53–83) 39.20 ± 7.89 (27–47)
Symptoms (n) Chest pain: 18 Chest pain: 3 Chest pain: 9 —





Course of disease (months) 0.13 ± 1.66 62.82 ± 168.61 41.88 ± 49.74 —
Operation AO + AR + AVR + DAE: 7 AOR: 3 Off-pump coronary —
AOR + AVR: 3 AOR + AVR: 2  artery bypass: 4
AR + DAE: 1 AR: 1 CABG: 4
AO + AR + AVR: 2 Thoracic + abdominal Beating heart coronary
AOR + DAE: 2 aorta replacement: 1  revascularisation: 1
AO + AR + DA: 1 DA replacement: 1
AOR + AVR + DA: 1 Bentall operation: 1
AOR + AVR + DAE + tricuspid
De Vega annuloplasty: 1
AOR + AVR + arch exclusion: 1
AOR: 1
Survival (%) 100 85 100 —
AO — ascending aorta; AOR — ascending aorta replacement; AR — arch replacement; AVR — aortic valve replacement; CABG — coronary artery bypass grafting;
CAD — coronary artery disease; DA — descending aorta; DAE — descending aorta exclusion
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study subjects. This study was approved by the Insti-
tutional Ethical Committee and was conducted fol-
lowing the guidelines of the Declaration of Helsinki.
Informed consent was obtained from each patient.
The aortic tissue samples were fixed in 10%
methanol solution in 1 cm3 blocks, embedded in par-
affin wax, processed routinely, and stained with hae-
matoxylin-eosin (H&E) on 4 mm sections. Staining of
collagen fibres was performed with Masson’s
trichrome protocol, elastic fibre staining was conduct-
ed following van Gieson staining, and glycosami-
noglycans were stained by alcian blue-periodic acid
Schiff method. An immunohistochemical staining
technique using the EnVision antibody complex was
applied on 4 mm paraffin-embedded sections to de-
tect TGF-b1, TbRI, Smad2/3, Smad4, and Smad7.
The following primary antibodies were utilised:
TGF-b1 (Y369) (1:100) (Bioworld Technology, Inc.,
Louis Park, MN, USA), TbRI (E161) (1:100) (Bioworld
Technology, Inc., Louis Park, MN, USA), Smad2/3 (S2)
(1:100) (Bioworld Technology, Inc., Louis Park, MN,
USA), Smad4 (L43) (1:100) (Bioworld Technology,
Inc., Louis Park, MN, USA), Smad7 (monoclonal)
(M09) (1:100) (Abgent Primary Antibody Company,
10239 Flanders Court, San Diego, CA 92121, USA),
Smad7 (Z8-B): sc-101152 (1:100) (Santa Cruz Bio-
technology, Inc., CA, USA).
The densities of the immunostaining were de-
fined as: – (background) as 0, + (weak yellow) as 1,
++ (yellow) as 2, and +++ (brown) as 3 in semi-
quantitative analyses. Photographs were taken at
a magnification of 100–400×.
Data were expressed as mean ± standard devia-
tion. One-way ANOVA analysis of variance and non-
parametric rank sum test were used for inter-group
analyses. Differences were considered to be statisti-
cally significant if p < 0.05.
RESULTS
H&E staining
In the aorta of aortic dissection extensive areas of
disruption or necrosis were present in the elastic fibres
of the weakening aortic media, while patchy necrosis,
fibrinous exudate, and local inflammatory cell infiltra-
tion comprised of neutrophils, macrophages, and eosi-
nophils could be seen near the tear of the aortic wall.
Scattered inflammation infiltration was observed in the
interstitial cells of the adventitia in only two of the aortic
aneurysm patients (a 58-year-old female patient with
ascending aortic aneurysm and a 42-year-old male pa-
tient with syphilic thoracic aortic aneurysm) and a 57-
-year-old male patient with subacute myocardial infarc-
tion. Aortic samples from the patients with aortic aneu-
rysm showed focal disruption and patchy necrosis of the
elastic fibres. Focal dissolutions of the elastic fibres of
the aortic media were seen in the aorta of the patients
with coronary artery disease. The aorta of the healthy
control individuals had normal architecture (Fig. 1).
Masson’s trichrome staining
In the Aortic Dissection Group there were diffuse
intimal thickening, fragmented elastic fibres of the
media with marked collagen deposition, and attenu-
ated muscular fibres in the retained media and inti-
ma. In the Aortic Aneurysm Group the intima of the
aorta was almost intact, the smooth muscle in the
aortic media became thinner and disarrayed, and fo-
cal elastic fibre disruptions appeared with more col-
lagen deposition. In the coronary artery disease pa-
tients the aortic structures were also disrupted but were
still dense, and the collagen deposition was less than
that seen in the aorta of the patients with aortic dis-
section or aortic aneurysm. The aortic structures were
intact in the Healthy Control Group (Fig. 2).
van Gieson staining
In the Aortic Dissection Group the intima was thick-
ening, and the medial smooth muscle cells were dif-
fusely disrupted, with extensive collagen deposition.
In the Aortic Aneurysm Group there was less collagen
deposition and significantly more muscular fibres in
the media than in the Aortic Dissection Group. In the
Figure 1. H&E stainings of the aorta showed: A. Extensive areas of
disruption or necrosis in the elastic fibres of the weakening aortic
media with patchy necrosis, fibrinous exudate, and inflammatory cell
infiltration in the Aortic Dissection Group; B. Focal disruption and
patchy necrosis of the elastic fibres of the media in the Aortic Aneu-
rysm Group; C. Focal dissolutions of the elastic fibres of the media in
the Coronary Artery Disease Group; D. Normal aortic architectures in
the Healthy Control Group. H&E×100 (inserts: H&E×400).
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Coronary Artery Disease Group the aortic structures
were disrupted less severely and showed less collagen
deposition in the media than in the Aortic Dissection
and Aortic Aneurysm Groups. The aortic wall was in-
tact and the collagens and elastic fibres were evenly
stained in the Healthy Control Group (Fig. 3).
Alcian blue-periodic acid Schiff staining
The aorta was severely fragmented, and acid
mucopolysaccharide deposition was most intense
in the adventitia, more intense in the intima, and
little or trace in various layers of the aortic media in
the Aortic Dissection Group. Moreover, grade III–IV
cystic medial necrosis was seen with dark blue acid
mucopolysaccharides depositing in the necrotic re-
gion. In the Aortic Aneurysm Group the acid muco-
polysaccharides deposited in the adventitia, media,
and intima, with the intima having the most depo-
sition but less than that of the Aortic Dissection
Group. In the aorta of the coronary artery disease
patients, there was less acid mucopolysaccharide
deposition in comparison to either the Aortic Dis-
section or Aortic Aneurysm groups, with grade I–II
cystic medial necrosis. In the aorta of the healthy
control individuals, only trace acid mucopolysaccha-
rides were evenly distributed in the normal aortic
elastic fibres (Fig. 4).
Immunohistochemistry
TGF-b1. Strong cytoplasmic staining (+++) of
TGF-b1 in the aortic media, weak cytoplasmic stain-
ing (+) in the adventitia, and weak to moderate cy-
toplasmic staining in the intima (+–++) was noted
in the Aortic Dissection Group. In the Aortic Aneu-
rysm Group, TGF-b1 cytoplasmic staining was weak
(+) in the intima, while in the media and adventitia
the cytoplasmic staining and the interstitial stain-
ing was moderate (++). In the Coronary Artery
Figure 3. van Gieson staining of the aorta showed: A. Intimal
thickening, diffusely disrupted smooth muscle cells with exten-
sive collagen deposition in the Aortic Dissection Group; B. Less
collagen deposition, and significantly more muscular fibres in the
media in Aortic Aneurysmal Group than in the Aortic Dissection
Group; C. Less severe disruption and less collagen deposition in
the media in the Coronary Artery Disease Group than in the Aortic
Dissection and Aortic Aneurysm Groups; D. The evenly stained
collagens and intact elastic fibres in the Healthy Control Group.
van Gieson×100 (inserts: van Gieson×400).
Figure 4. Alcian blue-periodic acid Schiff staining of the aorta
showed: A. Severely fragmented elastic fibres and intense acid
mucopolysaccharide deposition in the adventitia, intima, and
media with with grade III–IV cystic medial necrosis in the Aortic
Dissection Group; B. Acid mucopolysaccharides deposition in the
Aortic Aneurysm Group, but less than that of the Aortic Dissection
Group; C. Less acid mucopolysaccharide deposition with milder
cystic medial necrosis in the aorta of the coronary artery disease
patients in comparison to the Aortic Dissection or Aortic Aneurysm
Group; D. Trace acid mucopolysaccharide deposition in the Healthy
Control Group. AB-PAS×200 (inserts: AB-PAS×400).
Figure 2. Masson’s trichrome staining of the aorta showed more
collages in the aortic dissection (A) and aortic aneurysm (B) than
in the coronary artery disease patients (C) and the healthy indi-
viduals (D). Masson×100 (inserts: Masson×400).
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Disease Group the cytoplasmic staining of TGF-b1 was
moderately to intense (++–+++) in the aortic me-
dia, and weak (±–+) in the intima and adventitia.
In the aorta of the healthy control individuals the
cytoplasmic stainings of TGF-b1 were even in the in-
tima, media, and adventitia with a staining intensi-
ty of weak to moderate (+–++) (Fig. 5). There was
no nuclear staining.
TbRI. The cytoplasmic immunostaining of TbRI
was located in the aortic media. In the Aortic Dis-
section Group, the aortic wall structures were disar-
rayed and the intima was disrupted, and the cyto-
plasmic staining of TbRI was moderate (++) in the
aortic media and weak (±–+) in the intima and ad-
ventitia. In the Aortic Aneurysm Group the cytoplas-
mic staining of TbRI was weak to moderate (+–++)
in the intima, media, and adventitia. In the Coro-
nary Artery Disease Group the cytoplasmic staining
was moderate (++) in the aortic media. The immu-
nostaining of TbRI was negative (–) in the aortic
media, but a weak cytoplasmic staining (+) in the
intima was noted in the aorta of the healthy control
individuals (Fig. 6). No nuclear staining was noted.
Smad2/3. A weak cytoplasmic staining of
Smad2/3 in the media and a moderate to intense
cytoplasmic staining (++–+++) in the intima was
observed in the Aortic Dissection Group. Intense cyto-
plasmic and interstitial stainings (+++) of Smad2/3
were seen in the aortic media, but a moderate
cytoplasmic staining (++) was seen in the intima in
the Aortic Aneurysm Group. The cytoplasmic stain-
ing of Smad2/3 was intense (+++) in part of the
aortic media of the coronary artery disease patients,
while the cytoplasmic staining of Smad2/3 was weak
(+) in the intima, media, and adventitia of the aor-
ta of the healthy control (Fig. 7). No nuclear stain-
ing was shown.
Smad4. A weak cytoplasmic staining of Smad4
(+) in the intima and a moderate cytoplasmic stain-
ing (++) in the media were present in the Aortic
Dissection Group. Cytoplasmic and local interstitial
immunostainings of Smad4 were moderate to in-
tense (++–+++) in the intima, media, and adven-
titia in the Aortic Aneurysm Group. Cytoplasmic
Figure 6. Immunohistochemistry of TbRI of the Aortic Dissection
(A), Aortic Aneurysm (B), Coronary Artery Disease (C), and
Healthy Control Groups (D) illustrated a cytoplasmic reactivity in
each group. The three experimental groups had more intense
stainings in comparison to the Healthy Control Group.
EnVision×100 (inserts: EnVision×400).
Figure 7. Immunohistochemistry of Smad2/3 of the Aortic Dissec-
tion (A), Aortic Aneurysm (B), Coronary Artery Disease (C), and
Healthy Control Groups (D). Smad2/3 immunoreactivity was cyto-
plasmic in each group, but the locations varied from intima to media
with different aetiologies. EnVision×100 (inserts: EnVision×400).
Figure 5. Immunohistochemistry of TGF-b1 of the Aortic Dissec-
tion (A), Aortic Aneurysm (B), Coronary Artery Disease (C), and
Healthy Control Groups (D). Note the intensity differences of the
cytoplasmic immunoreactivities in the media of each group.
EnVision×100 (inserts: EnVision×400).
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staining also prevailed in the aorta of the coronary
artery disease patients, with a moderate to intense
staining (++–+++) in the intima and a moderate
(++) staining in the media. In the aortic tissues of
the healthy control, the immunostaining of Smad4
was both cytoplasmic and nuclear, which was weak
(+) in the intimal and subintimal layers. A negative
or weak cytoplasmic staining (– – +) was observed
positive in part of the media, and weak cytoplasmic
and interstitial stainings (+) were shown in the ad-
ventitia of the aorta of the healthy control (Fig. 8).
Smad7 (Abgent primary antibody). The nucle-
ar staining of Smad7 was intense (+++) in the inti-
ma and part of the media, and the interstitial stain-
ing of Smad7 was weak to moderate (+–++) in the
media of the aorta of the aortic dissection patients.
The nuclear staining of Smad7 was moderate (++)
in the media and part of the subintimal layers in the
aortic aneurysm patients. The nuclear staining of
Smad7 was intense (+++) in the aortic media of the
coronary artery disease patients. In the healthy con-
trol, Smad7 staining was nuclear, which was weak (+)
and confined to the subintimal layer, while weak or
negative (– – +) in the minority of the media (Fig. 9).
Smad7 (Santa Cruz primary antibody). The
nuclear staining of Smad7 was intense (+++) in the
subintima and part of the media and was moderate
(++) in the interstices of the media of the aorta of
the aortic dissection patients. It was weakly to mode-
rately positive (+–++) in part of the media and sub-
intimal layers in the aorta of the aortic aneurysm pa-
tients. An intense nuclear staining (+++) of Smad7
was shown in the media of the aorta of the coronary
artery disease patients. In the healthy control, Smad7
was only weakly positive (+) in the subintimal nu-
clei, while negative (–) in the media (Fig. 10).
The immunostaining positive rates for all cells of
the aorta were summarised in Table 2. No statistical
differences were found in the immunostaining in-
tensities of each protein between groups.
Figure 9. Immunohistochemistry of Smad7 (Abgent primary anti-
body) of the Aortic Dissection (A), Aortic Aneurysm (B), Coronary
Artery Disease (C), and Healthy Control Groups (D). The nuclear
stainings of Smad7 were located predominantly in the intima, subin-
tima, and media, where the intensities of the stainings were more in
the Aortic Dissection and Coronary Artery Disease Groups than in
the other two groups. EnVision × 100 (inserts: EnVision×400).
Figure 10. Immunohistochemistry of Smad7 (Santa Cruz primary
antibody) of the Aortic Dissection (A), Aortic Aneurysm (B),
Coronary Artery Disease (C), and Healthy Control Groups (D).
The immunostaining results were similar to those obtained
by using Abgent primary antibody. EnVision×100
(inserts: EnVision×400).
Figure 8. Immunohistochemistry of Smad4 of the Aortic Dissec-
tion (A), Aortic Aneurysm (B), Coronary Artery Disease (C), and
Healthy Control Groups (D). The immunoreactivities were chiefly
cytoplasmic in the media with a few being interstitial in the three
experimental groups. Nuclear stainings could be noted in the inti-
mal and subintimal layers, with negative or weak cytoplasmic
staining in the media in the Healthy Control Group.
EnVision×100 (inserts: EnVision×400).
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DISCUSSION
TGF-b1 is one of the cytokines that protect ves-
sels from atherosclerosis and prevent the aorta from
dilation via cellular structural changes, collagen lip-
id deposition, and gene expression alterations of the
aortic wall [8]. In the smooth muscle cells, TGF-b1
may promote the phosphorylation of Smad2 and
Smad3 through activin-like kinase 5 (ALK5) and then
bind to Smad4, translocating into the nucleus to
interact with the transcription factors and regulate
the response gene of TGF-b [23].
Special stainings, including Masson’s trichrome, van
Gieson, and Alcian blue methods, are important tech-
niques identifying the elastofibrotic structures or the
content of acid mucopolysaccharides of the aorta. Of
them, van Gieson stain is used for elastin to evaluate
the coronary arterial intimal lesions, and Masson’s
trichrome stain, to evaluate fibrosis [19]. In the previous
reports the elastofibrotic disruption was termed as de-
grees 1, 2, and 3, when the lesions of disruption were
£ 5, 5–10, and ≥ 10, respectively [2, 5]. Under pathologi-
cal observations the elastofibrosis was in well-arranged
laminar structures in the normal aorta while the elastic
proteins were remarkably reduced with loss of the or-
dered laminar arrangement in the aorta of Marfan’s pa-
tients [22]. Moreover, van Gieson staining of the aorta
from the patients with aortic aneurysm showed elastofi-
brotic disruption of degree 3 in more than 10 of the
adjacent elastofibrotic laminas [17]. Alcian blue stain-
ing has shown increased contents of acid mucopolysac-
charides in the heart valves of mucoid degeneration [21].
Histologically, either mediolytic or dysplastic changes
may predispose to develop in the medial layers of the
arteries, thereby leading to a medial degeneration char-
acterised by focal fibrosis, loss of smooth muscle cells,
and elastic fibres with accumulation of eosinophilic
ground substances in the diseased aorta [12].
It has been demonstrated that the pathogenesis
of the aortic aneurysmal dilation resulted from TGF-b1
overexpression that was associated with the apopto-
sis and decreased proliferation of the smooth muscle
cells within the dilated aorta [9]. In other words, the
expressions of TGF-b1 were typically associated with
the inhibition of the proliferation of the vascular
smooth muscle cells [11]. Medial degeneration with
elastofibrotic disruption was a common characteristic
of aortic dissection and aortic aneurysm, as described
by Yang et al. [26]. TGF-b1, based on their further ob-
servations, was unevenly distributed in the aortic wall,
with the highest expression in the media, higher ex-
pression in the intima, lowest in the adventitia, and
a significant lower expression in the aortic dissection
than that in the aortic aneurysm. Unfortunately, an
errant conclusion can be drawn from their results that
the TGF-b1 accumulation in the remnant undisrupted
elastic structures, which was more likely to be a con-
tradiction of the popularly accepted apoptotic con-
cepts [9]. Gomez et al. [10] conducted an immunohis-
tochemical study on aortic aneurysms of different
aetiologies, such as Marfan’s syndrome, bicuspid
aortic valve, or degenerative changes, and found that
TGF-b1 was upregulated in the outer media and ad-
ventitia with no differences between aetiologies.
Ruling out Marfan’s syndrome is important as it
may refer to variable underlying aetiologies with
probable different TGF-b activation.
The TGF-b1 protein was mainly found in the cyto-
plasm [20]. TbRI is a transmembrane protein also
mainly expressed on the cell membrane primarily lo-
cated on the basolateral surface of the polarised ep-
ithelial cells but also found to be localised in the cy-
toplasm and nucleus [15]. R-Smads are predominantly
localised in the cytoplasm, the I-Smads are in the
nucleus, and the Co-Smad is in both cytoplasm and
the nucleus [25]. The antibodies used in the present
study were carefully chosen based on the above-men-
tioned rationales so as to get the highest possible
potency ratios in the immunohistochemical studies.
In this study, ruling out Marfan’s syndrome is im-
portant as it may refer to variable underlying aetiolo-
gies probably with different TGF-b activation. More se-
vere elastic fibre disruption, more collagen deposition,
Table 2. The positive rates of the immunostainings for all cells of the aortic wall (%)
Group TGF-b1 TbRI Smad2/3 Smad4 Smad7 Smad7
(Abgent) (Santa Cruz)
Aortic dissection 80 20–40 33.3 80 80 80–100
Aortic aneurysm 100 100 80 100 50 100
Coronary artery disease 80 100 60 83.3 75 100
Healthy control 80 16.7 40 50 75 60–80
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and more accumulation of eosinophilic ground sub-
stances with cystic medial necrosis in the aortic tissues
of the aortic dissection patients in comparison to the
controls were observed. The results may become the
underlying causes for the enhanced TGF-b1 signalling
pathway. This study also illustrated analogous upregu-
lations of the proteins involved in the TGF-b1 signalling
pathway in the aortic tissues between aortic dissection
and aortic aneurysm. As well as the ligand TGF-b1 and
the receptor TbRI, Smad4 and Smad7 might play a key
role in the regulation of the pathological processes of
these aortic disorders. In contrast, the aortic expressions
of the investigated proteins were somewhat less pro-
nounced in the coronary artery disease patients, while
negative in the normal control samples. These results
were in agreement with those reported by Costello et
al. [3]. The predilections of cytoplasmic/nuclear stain-
ings in the media indicated the locations where the sig-
nalling pathway played the biological functions.
There were several limitations to this study: small
sample, small aortic tissues from the coronary artery
disease patients, and a lack of normal aortic tissues
from heart transplant donors. Studies on the basis of
abundant samples from a large patient population
of each study group may offer more reliable results.
CONCLUSIONS
These observations support the notion that there
is an association between the TGF-b1/Smad pathway
and the pathological events of the aorta. Dysregu-
lation of the TGF-b1/Smad pathway may predispose
the pathologenesis of the aortic disorders.
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